Coronary MR angiography: Experimental results with a monomer-stabilized blood pool contrast medium

Radiology

Volumn 222, Issue 1, 2002, Pages 120-126

  Taupitz, M ^a   Schnorr, J ^a   Wagner, S ^a   Abramjuk, C ^a   Pilgrimm, H ^a   Kivelitz, D ^a   Schink, T ^a   Hansel, J ^a   Laub, G ^a   Hunigen H ^a   Hamm, B ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Contrast media, experimental studies; Gadolinium; Magnetic resonance (MR), contrast media; Magnetic resonance (MR), vascular studies

Indexed keywords

CITRIC ACID; CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; MONOMER; SUPERPARAMAGNETIC IRON OXIDE; VSOP C91;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY; DIAGNOSTIC VALUE; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SWINE;

EID: 0036136064     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2221001452     Document Type: Article

References (24)

1. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients
2. Benefit of T1 reduction for magnetic resonance coronary angiography: A numerical simulation and phantom study
3. Coronary arteries: Breath-hold, gadolinium-enhanced, three-dimensional MR angiography
4. Breath-hold coronary MR angiography with volume-targeted imaging
5. Three-dimensional gadolinium-enhanced coronary magnetic resonance angiography: Initial experience
6. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: Preclinical results in rats and rabbits
7. Gadolinium chelates with weak binding to serum proteins: A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
8. Non-parametric hypothesis and rank statistics for unbalanced factorial designs
9. Efficacy of slow infusion of gadolinium contrast agent in three- dimensional MR coronary artery imaging
10. Phase I clinical evaluation of a new iron oxide MR contrast agent
11. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children
12. Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El (oxethylated castor oil) and Triton X100: A possible explanation for unexpected adverse drug reactions?
13. In vitro release of histamine from murine mast cells by block co-polymers composed of polyoxyethylene and polyoxypropylene
14. Superparamagnetic iron oxide: Pharmacokinetics and toxicity
15. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
16. Safety and preliminary findings with the intravascular contrast agent NC100150 Injection for MR coronary angiography
17. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: Preliminary results of an animal study original investigation
18. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography
19. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities
20. Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits
21. Frequency dependence of MR relaxation times. II. Iron oxides
22. Three-dimensional MRI of coronary arteries using an intravascular contrast agent